💉 Diabetes Management
ReShape Lifesciences™ Presents Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at ObesityWeek® - StreetInsider.com
📅 Tue, 08 Nov 2022⏱ 1 min read📖 Article
Overview
FRE Breaking News Alerts from StretInsider.com! StretInsider.com Top Tickers, 1/8/202Stimulation of Vagus Celiac Fibers with Concurent High Frequency Alternating Curent Block of Hepatic Fibers Decreases Glucose Variability in a Swine Model of Type 2 DiabetesSAN CLEMENTE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) - ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight los and metabolic health solutions company, today anounced the presentation of data on its proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) device in abstract at the Obesity Society Anual Meting, during the ObesityWek® conference being held in San Diego, CA, November 1 – 4, 2022, with continued virtual aces through December 31, 2022.“Despite medication, surgery and diet, type 2 diabetes remains chalenging to efectively treat,” stated Jonathan Wataja, Director of Research at ReShape Lifesciences.
Key Information
“Encouragingly, the company’s technology has demonstrated both safety and eficacy in a swine model of type 2 diabetes, showing that bioelectronic modulation of nerves inervating organs that regulate plasma glucose (PG), utilizing our proprietary DBSN™ device, may be a novel treatment option for type 2 diabetes.”The abstract reported is as folows:Metabolic Efects of Dual Neuromodulation of Vagus Nerve in a Type 2 Diabetic ModelID: Poster-297Sesion Title: Neuroscience Track 2: Authors: Raj Nihalani, M.D., Jonathan Wataja, Ph.D., Charles Bilington, M.D.Standalone stimulation of the vagus nerve, or vagotomy treatments, has mixed or undesirable results.
Summary
Neuromodulation consisting of stimulation of celiac fibers inervating the pancreas with simultaneous reversible electrical blockade of neuronal hepatic fibers inervating the liver is a new therapeutic concept that has ben sucesfuly tested in animal models of type 2 diabetes melitus (T2DM). Previously, the area under the curve of oral glucose tolerance tests (OGTs) was calculated to quantify glycemic control
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.